• matt-april.gif
  • Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • About Us
  • Advertise
  • Contact
  • Send news and story ideas
North Shore Daily Post

North Shore Daily Post

Follow Us

News for North Shore in British Columbia

Wednesday April 21, 2021
  • HOME
  • North Shore
  • BC/Canada
  • World
  • Life
  • Voices
  • Stem-ad.png
  • Lynn-Valley-ad.jpg

Sales of cancer medicines in Canada tripled in 10 years

STAFF REPORT
October 27, 2020 12:17pm

Patented Medicine Prices Review Board has revealed that sales of oncology medicines in Canada have nearly tripled over the past decade, reaching $3.9 billion in 2019, or approximately 15% of all pharmaceutical spending.

In addition, the market has shifted toward higher-cost drugs, as medicines with 28-day treatment costs exceeding $7,500 now account for more than half of overall Canadian oncology sales. In Canada’s private drug plans, these high-cost therapies made up 43% of oncology drug costs in 2019, compared to 17% in 2010.

This information is contained in a chartbook on the market for oncology medicines in Canada released by the Board today.

QUICK FACTS

Per capita oncology sale in Canada remained below most comparator countries in 2019, though a recent rise in spending has narrowed the gap between Canadian and international levels.

Recent trends show a greater international alignment in the prices of oncology medicines, though Canadian prices continue to sit above those in comparator countries.

Over the last decade, the Canadian oncology market has shifted significantly towards higher-cost drugs. Medicines with 28-day treatment costs over $7,500 now account for more than half of all oncology sales in Canada, a sharp increase from 16% in 2010.

The Canadian oncology market is largely driven by new medicines, with medicines introduced after 2010 accounted for 58% of oncology sales in 2019, compared to 24% of non-oncology sales. Canadian availability for the top-selling new medicines in the OECD is in line with comparator countries.

High-cost oncology medicines account for a growing share of drug costs in Canada’s private drug plans. Shares differ greatly across jurisdictions, likely due to differences in public coverage for oral therapies, which now make up half of all oncology sales in Canada.

Share

Reader Interactions

Comments

NOTE: The North Shore Daily Post welcomes your opinions and comments. We do not allow personal attacks, offensive language or unsubstantiated allegations. We reserve the right to edit comments for length, style, legality and taste and reproduce them in print, electronic or otherwise. For further information, please contact the editor or publisher, or see our Terms and Conditions.

No Comments

Leave a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • craig-1.jpg
  • winslow.jpg
SUBSCRIBE FOR OUR NEWSLETTER

Recommended Stories

https://i2.wp.com/www.northshoredailypost.com/wp-content/uploads/2021/02/Magpie-river.jpg?fit=400%2C278&ssl=1
BC/Canada
A Canadian river gets legal personhood and rights
https://i1.wp.com/www.northshoredailypost.com/wp-content/uploads/2021/02/tram-Grand-boulevard-e1614103692768.jpg?fit=400%2C235&ssl=1
North Shore
Finding heritage: The landmarks of Grand Boulevard
https://i0.wp.com/www.northshoredailypost.com/wp-content/uploads/2019/11/Lynn-PARK.jpg?fit=400%2C223&ssl=1
North Shore
DNV moves to amend bylaw for pass exemption at Lynn Canyon
https://i2.wp.com/www.northshoredailypost.com/wp-content/uploads/2021/02/Dr-Zac-Hudson.jpg?fit=400%2C265&ssl=1
Life
UBC chemist helps create new compostable coffee pod
https://i0.wp.com/www.northshoredailypost.com/wp-content/uploads/2021/02/Kid-vegetables.jpg?fit=400%2C278&ssl=1
World
A fully vegan preschool set to open in Australia

Footer

Contact Us: contact@northshoredailypost.com

Follow Us

Copyright ©2020 North Shore Daily Post. All Rights Reserved
  • About Us
  • Advertise
  • Privacy Policy
  • Terms and Conditions